New investigations into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are demonstrating promising results in managing obesity and diabetes 2 condition. Animal information suggest a distinct mechanism https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/